Last reviewed · How we verify
NCT06018454: PGT-A
Preimplantation Genetic Testing for Aneuploidy Counseling
NA trial testing Handout on PGT-A in Patient Education in 213 participants. Completed in 29 November 2024.
30 October 2024
Quick facts
| Lead sponsor | Eyup Hakan Duran |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 213 |
| Start date | 20 December 2022 |
| Primary completion | 30 October 2024 |
| Estimated completion | 29 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Handout on PGT-A
- Handout on PGT-A and genetic counseling
Conditions studied
- Patient Education — all drugs for Patient Education →
Sponsor
Eyup Hakan Duran
Who can join
Adults 18 to 45, any sex, with Patient Education. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose: To evaluate preimplantation genetic testing counseling interventions on patients undergoing in vitro fertilization treatment. Preimplantation genetic testing for aneuploidy (PGT) allows patients undergoing in vitro fertilization (IVF) to screen embryos for genetic disorders. Preimplantation genetic testing for aneuploidy (PGT-A) is the testing most commonly ordered, and it screens for whole chromosome and large partial chromosome duplications or deletions. Currently, patient counseling varies based on the clinic, ranging from appointments to group seminars with a genetic counselor (GC), geneticist or reproductive endocrinology and infertility (REI) physicians for education regarding PGT. Patient knowledge regarding PGT has been varied with some studies indicating sufficient knowledge, while other studies have shown a potential lack of knowledge. One study indicated a third of patients had regret regarding their decision of whether or not to use PGT-A during IVF and another study indicated patients who choose to undergo PGT did so for reasons that were not evidence based. Additionally, educational materials have been illustrated to be inconsistent and with inappropriate literacy in regards to PGT counseling. One study has shown the potential of improvement with written intervention amongst providers and patients in regards to PGT related to a single genetic condition. The investigators hope to assess the efficacy of PGT-A educational and counseling interventions on patients undergoing IVF.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized controlled trial of counseling and educational methods on preimplantation genetic testing for aneuploidy for patients pursuing in vitro fertilization.
Singh P, Summers KM, Chanouha N, Thoeny R, et al · · 2025 · PMID 40523553 · DOI 10.1016/j.fertnstert.2025.06.010
Verify or expand the search:
- PubMed search for NCT06018454
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patient Education
Currently open trials in the same condition.
- NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
- NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
- NCT07278622 — Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial · NA · recruiting
- NCT07324343 — Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Co · NA · recruiting
- NCT06984354 — Digitally Delivered Treatments to Reduce Chronic Low Back Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06018454 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eyup Hakan Duran
- Last refreshed: 24 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06018454.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing